0.00
前日終値:
$23.50
開ける:
$0
24時間の取引高:
0
Relative Volume:
0.00
時価総額:
$151.86M
収益:
$102.16M
当期純損益:
$-35.69M
株価収益率:
0.00
EPS:
-5.7327
ネットキャッシュフロー:
$-7.08M
1週間 パフォーマンス:
-100.00%
1か月 パフォーマンス:
-100.00%
6か月 パフォーマンス:
-100.00%
1年 パフォーマンス:
-100.00%
Assertio Holdings Inc Stock (ASRT) Company Profile
名前
Assertio Holdings Inc
セクター
電話
(224) 419-7106
住所
100 S. SAUNDERS ROAD, LAKE FOREST, IL
Compare ASRT vs TAK, HLN, TEVA, ZTS, UTHR
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
ASRT
Assertio Holdings Inc
|
0.00 | 151.86M | 102.16M | -35.69M | -7.08M | -5.7327 |
|
TAK
Takeda Pharmaceutical Co Adr
|
17.65 | 55.69B | 29.91B | 1.30B | 3.49B | 0.4056 |
|
HLN
Haleon Plc Adr
|
10.26 | 43.77B | 14.54B | 2.22B | 2.58B | 0.4871 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.19 | 36.19B | 17.53B | 1.58B | 444.18M | 1.3457 |
|
ZTS
Zoetis Inc
|
78.42 | 32.25B | 9.51B | 2.64B | 2.14B | 6.0361 |
|
UTHR
United Therapeutics Corp
|
530.12 | 26.29B | 3.17B | 1.29B | 1.01B | 27.09 |
Assertio Holdings Inc Stock (ASRT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-04-09 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2024-07-26 | 開始されました | Maxim Group | Buy |
| 2024-07-03 | 開始されました | H.C. Wainwright | Buy |
| 2022-11-07 | 開始されました | Lake Street | Buy |
| 2018-11-30 | ダウングレード | Mizuho | Buy → Neutral |
Assertio Holdings Inc (ASRT) 最新ニュース
ASRT5746402 Bond Coupon Profile — Rate & Payments - TradingView
ASRT5746402 Bond Profile — Key Metrics - TradingView
Press Release: Assertio Provides Update on Garda Therapeutics Tender Process - Moomoo
Assertio Beats Investor Suit Over Drug, Merger Claims - Law360
Assertio Investors Fail to Advance Suit Over Spectrum Merger (1) - Bloomberg Law News
Assertio (ASRT) Small-Cap Growth Virtual Investor Conference Summary - Quartr
Assertio (ASRT) Proxy Filing Summary - Quartr
ASRT Stock Drops After-Hours On Discounted Buyout Deal — Retail Calls It A ‘Robbery’ - Stocktwits
Assertio (ASRT) Q2 2024 earnings summary - Quartr
Assertio Holdings (ASRT) Holds Steady Near Resistance as Trading Volume Remains SubduedSector ETF Flow - Bölüm Sonu Canavarı
Assertio Holdings (NASDAQ: ASRT) common stock struck from Nasdaq list - Stock Titan
Assertio Holdings (ASRT) Holds Steady Amid Consolidation at $23.50Gamma Flip Level - dars.gov.et
Assertio Deadline Alert - TMX Newsfile
ASRT CLASS ACTION NOTICE: Kessler Topaz Meltzer & Check, LLP Reminds Assertio Holdings, Inc. (ASRT) Shareholders of Securities Fraud Class Action Lawsuit and Encourages Investors with Substantial Losses to Contact the Firm - TMX Newsfile
Zydus Lifesciences Completes Acquisition of Assertio Holdings - Machine Maker
[15-12G] Assertio Holdings, Inc. SEC Filing - Stock Titan
ASRT Q1 2026 Earnings: Steep EPS Miss Amid Silent Revenue DisclosuresLong-Term Guidance - dars.gov.et
Zydus’s acquisition of Assertio to bolster its specialty pharma presence in US market - Indian Pharma Post
Zydus Lifesciences Completes Acquisition of Assertio; Nasdaq Delisting Confirmed - Digital Health News
Assertio Holdings Inc (ASRT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Assertio Holdings Inc (ASRT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Assertio Holdings Inc (ASRT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Zydus Acquires Assertio for Oncology Growth - Chemical Industry Digest
[EFFECT] Assertio Holdings, Inc. SEC Filing - Stock Titan
Assertio Holdings Inc (ASRT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Zydus Completes USD 166.4 Million Acquisition of US-Based Assertio Holdings - Medical Dialogues
Key facts: Assertio appoints two directors; Nasdaq halt, delisting - TradingView
Assertio Holdings Completes Merger with Zydus Lifesciences; Shareholders Receive $23.50 Per Share in Cash 1 - Minichart
Zydus Lifesciences Completes Acquisition of US-Based Assertio Holdings - marketscreener.com
Zydus Lifesciences shares fall 2% as firm acquires US-based Assertio Holdings for $166 million - inkl
Assertio completes $23.50 per share merger with Zydus - Investing.com UK
Assertio (ASRT) director fully cashes out shares and options in Zydus $23.50-per-share merger - Stock Titan
Zydus buys Assertio (ASRT); EVP Schlessinger equity cashed out at $23.50 - Stock Titan
Assertio Holdings (ASRT) director exits as Zydus cash merger pays $23.50 - Stock Titan
Assertio (ASRT) director’s shares and options cashed out in $23.50 Zydus buyout - Stock Titan
Assertio (ASRT) COO exits stock, options and RSUs in $23.50-per-share cash merger - Stock Titan
Assertio (ASRT) CEO exits all shares and awards in $23.50-per-share cash merger - Stock Titan
Assertio (ASRT) director cashes out shares and options in Zydus merger - Stock Titan
Assertio (ASRT) director fully cashed out as $23.50-per-share merger closes - Stock Titan
CFO Ajay Patel exits Assertio (ASRT) stake in $23.50-per-share merger - Stock Titan
Zydus completes Assertio acquisition, notes repurchase rights triggered - scanx.trade
Assertio Amends 2027 Convertible Notes After Merger; Holders Get Cash-Only Conversion, Put Right - TradingView
Assertio Holdings (ASRT) completes merger; deregisters $250M shelf capacity - Stock Titan
Assertio Holdings (ASRT) deregisters S-4s after $23.50 cash tender and merger - Stock Titan
Acquirer completes Assertio deal; ASRT removed registered shares after $23.50 tender - Stock Titan
Assertio completes $23.50 per share merger with Zydus By Investing.com - Investing.com Australia
Assertio Holdings, Inc. Announces Board and Committee Changes, Effective June 16, 2026 - marketscreener.com
Zydus buys Assertio (NASDAQ: ASRT) in $23.50‑per‑share all‑cash deal - Stock Titan
Zydus deal gives Assertio holders $23.50 cash per share - Stock Titan
Zydus Lifesciences completes acquisition of Assertio - ET Manufacturing
Zydus Lifesciences shares in focus on completing acquisition of Assertio Holdings; key details - Upstox
Assertio Holdings Inc (ASRT) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):